Renal agenesis, bilateral

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1848OMIM:191830Q60.1
Who is this for?
Show terms as
2Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Bilateral renal agenesis (BRA), also known as Potter syndrome or Potter sequence, is a severe congenital condition characterized by the complete absence of both kidneys at birth. This condition arises from a failure of kidney development during embryogenesis. Without functioning kidneys, the fetus cannot produce urine, which is the primary contributor to amniotic fluid during the second and third trimesters of pregnancy. The resulting severe oligohydramnios (critically low amniotic fluid) leads to a cascade of secondary abnormalities collectively known as Potter sequence, including pulmonary hypoplasia (underdeveloped lungs), characteristic facial features (flattened nose, recessed chin, low-set ears), and limb abnormalities due to compression in utero. Bilateral renal agenesis is a lethal condition in the vast majority of cases. Affected infants are typically stillborn or die within hours to days after birth, primarily due to respiratory failure caused by severely underdeveloped lungs. The condition can be detected prenatally through ultrasound, which may reveal absent kidneys and severe oligohydramnios, typically becoming apparent in the second trimester. Additional prenatal findings may include absence of the fetal bladder. The condition affects the urogenital system broadly, and associated anomalies of the genital tract, cardiovascular system, gastrointestinal tract, and musculoskeletal system may also be present. Bilateral renal agenesis can occur as an isolated finding or as part of a broader genetic syndrome. It may arise sporadically or follow an autosomal dominant pattern with incomplete penetrance and variable expressivity, particularly in familial cases linked to mutations in genes such as RET, FGF20, or ITGA8. Some cases are associated with autosomal recessive inheritance. Currently, there is no curative treatment. Management is primarily supportive and palliative. Experimental approaches including serial amnioinfusion during pregnancy and postnatal peritoneal dialysis followed by kidney transplantation have been explored in a very limited number of cases, but these remain investigational and outcomes are uncertain. Genetic counseling is recommended for affected families, as first-degree relatives may carry unilateral renal agenesis or other renal anomalies.

Clinical phenotype terms— hover any for plain English:

Nonketotic hypoglycemiaHP:0001958Fetal polyuriaHP:0001563Abnormal intestine morphologyHP:0002242Abnormal sacrum morphologyHP:0005107Urogenital fistulaHP:0100589SirenomeliaHP:0010497
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Renal agenesis, bilateral.

View clinical trials →

No actively recruiting trials found for Renal agenesis, bilateral at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Renal agenesis, bilateral community →

Specialists

2 foundView all specialists →
MM
Mauro Schenone, MD
ROCHESTER, MN
Specialist
PI on 4 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Renal agenesis, bilateral.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Renal agenesis, bilateralForum →

No community posts yet. Be the first to share your experience with Renal agenesis, bilateral.

Start the conversation →

Latest news about Renal agenesis, bilateral

No recent news articles for Renal agenesis, bilateral.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Renal agenesis, bilateral

What is Renal agenesis, bilateral?

Bilateral renal agenesis (BRA), also known as Potter syndrome or Potter sequence, is a severe congenital condition characterized by the complete absence of both kidneys at birth. This condition arises from a failure of kidney development during embryogenesis. Without functioning kidneys, the fetus cannot produce urine, which is the primary contributor to amniotic fluid during the second and third trimesters of pregnancy. The resulting severe oligohydramnios (critically low amniotic fluid) leads to a cascade of secondary abnormalities collectively known as Potter sequence, including pulmonary h

At what age does Renal agenesis, bilateral typically begin?

Typical onset of Renal agenesis, bilateral is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Renal agenesis, bilateral?

2 specialists and care centers treating Renal agenesis, bilateral are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.